The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy in men with intermediate-risk prostate cancer.
Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A ...
Abstract: Urological health is a global concern since urologic cancers that remain undiagnosed and untreated, mostly kidney, bladder, and prostate cancer, can lead to ghastly physical, psychological, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results